In infants with BA who have undergone Kasai portoenterostomy, the effect of administering three consecutive days of granulocyte-colony-stimulating-factor (G-CSF) on liver inflammation was examined in a phase 1 trial demonstrating that peripheral neutrophils and HSPCs initially increased before decreasing to baseline levels after two weeks. This evidence concerns the gene CSF3 and breast angiosarcoma.